- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05441683
Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics With Horizontal or Vertical Releasing Incisions
Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics (PAOO) With Horizontal or Vertical Releasing Incisions
The study aims to compare the effect of periodontal accelerated osteogenic orthodontics (PAOO) with horizontal or vertical releasing incisions on operation time, healing, adverse effects, and effectiveness of bone augmentation.
Methods: A total of 22 patients requiring PAOO surgery due to orthodontic treatment were enrolled in this trial, and randomly divided into test or control group, consisting of 11 subjects in each. The test group will receive PAOO with horizontal extending incisions on both sides of the flap; while the control group will receive PAOO with vertical releasing incisions; the two groups use the same surgical technic except for the incision design. Outcome measures include: operation time, postoperative scar, radiographic data (alveolar height and alveolar ridge thickness), gingival thickness, etc. Clinical evaluation will be performed at 1 week, 2 weeks, 3months, 6 months and 12 months after operation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
China
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Recruiting
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged between 18 and 40 years old, systemic healthy, undergoing or planning to undergo orthodontic treatment.
- Patients with a thin alveolar bone or with dehiscence and/or fenestration on the labial side of maxillary or mandibular front teeth area.
- Patients with expected tooth movement beyond the labial alveolar bone during orthodontic procedures.
Exclusion Criteria:
- Smoker.
- Pregnant or lactating.
- Untreated periodontitis.
- Presence of <2mm keratinized gingival width(KGW) or thin gingival phenotype (as defined by dental probe transparency.)
- History of orthodontic and/or orthognathic treatment.
- With systemic disease (diabetes, hypertension, heart disease, malignant tumor, severe mental illness, and other surgical contraindications.)
- Long-term medication (immunosuppressive drugs, bisphosphonates, etc.)
- Poor adherence to complete one-year follow-up.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: HEI
PAOO with horizontally extending incisions on both sides
|
An intrasulcular incision will be made on the labial side of the front teeth with a thin alveolar bone or dehiscence and/or fenestration.
Then horizontally extending incisions will be added to each side of the Intrasulcular incision, extending one to two teeth beyond the defected area, before a full-thickness flap is lifted.
|
ACTIVE_COMPARATOR: VRI
PAOO with vertical releasing incisions on both sides
|
An intrasulcular incision will be made on the labial side of the front teeth with a thin alveolar bone or dehiscence and/or fenestration.
Vertical releasing incisions will be made on each side of the intrasulcular incision before a full-thickness flap is lifted.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
surgury time
Time Frame: 1 day
|
Timing will start when the first incision is about to be made, and end when the last suture is complete.
The time in between will be recorded as surgury time.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
probing depth (PD)
Time Frame: 12 months
|
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
|
12 months
|
clinical attachment level (CAL)
Time Frame: 12 months
|
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
|
12 months
|
keratinized gingival width (KGW)
Time Frame: 12 months
|
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
|
12 months
|
gingival recession depth (GRD)
Time Frame: 12 months
|
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
|
12 months
|
gingival thickness (GT)
Time Frame: 12months
|
gingival phenotype as defined by dental probe transparency
|
12months
|
alveolar ridge height
Time Frame: 12 months
|
The height of the alveolar ridge, which is measured on CBCT from the most coronal point to the root apex.
|
12 months
|
alveolar ridge horizontal thickness
Time Frame: 12 months
|
measured on CBCT at the most coronal section, and 2mm, 4mm to the most coronal point, denoted as BW0, BW2, and BW4
|
12 months
|
facial swelling
Time Frame: 2 weeks
|
recorded "0" for no facial swelling; "1" for mild facial swelling; "2" for severe facial swelling.
|
2 weeks
|
pain level
Time Frame: 2 weeks
|
measured with VAS score
|
2 weeks
|
mucosal color
Time Frame: 2 weeks
|
recorded "0" for no redness along the incision; "1" for slight redness; "2" for obvious redness.
|
2 weeks
|
edema
Time Frame: 2 weeks
|
recorded "0" for no edema around the surgery area; "1" for mild edema; "2" for severe edema.
|
2 weeks
|
membrane exposure
Time Frame: 2 weeks
|
recorded "0" if there is no membrane exposure, and "1" if there is any membrane exposure.
|
2 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0271
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malocclusion
-
NCT05853211Not yet recruitingMalocclusion, Angle Class II
-
NCT05822271RecruitingMalocclusion, Angle Class III
-
NCT05792553Not yet recruitingOpen Bite | Tongue Habits
-
NCT05684510RecruitingMalocclusion | Class II Malocclusion
-
NCT05656898Recruiting
-
NCT05639725RecruitingClass II Div 1 Malocclusion
-
NCT05631353Not yet recruitingClass II Malocclusion
-
NCT05610150RecruitingMalocclusion, Angle Class II, Division 1
-
NCT05597748Not yet recruitingClass II Malocclusion